We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 983.00 | 980.00 | 983.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.82 | 704.94M |
TIDMCVSG
RNS Number : 9190B
CVS Group plc
15 January 2018
15 January 2018
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that 104,278 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued on 12 January 2018 as a result of the exercise of employee share options, in connection with the Company's December 2014 - December 2017 (January 2018 Maturity) 2017 Save As You Earn Scheme.
The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2017.
The Company also announces that 171 ordinary shares of 0.2 pence each (the "New Shares") were issued on 12 January 2018 as a result of the exercise of employee share options by a former employee, in connection with the Company's December 2015 - December 2018 (January 2019 Maturity) Save As You Earn Scheme.
Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 19 January 2018.
Following issue of the SAYE Shares and the New Shares, the Company's total issued share capital will consist of 64,516,671 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company is 64,516,671. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts:
CVS Group plc Tel: 01379 644 Simon Innes, Chief Executive 288 Nick Perrin, Finance Director N+1 Singer (Nominated Adviser Tel: 020 7496 & Broker) 3000 Aubrey Powell Liz Yong James Hopton
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEGGUCAGUPRGCA
(END) Dow Jones Newswires
January 15, 2018 09:55 ET (14:55 GMT)
1 Year Cvs Chart |
1 Month Cvs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions